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2. Materials and methods 
Abstract A fluorescent vinblastine analogue, vinblastine-4 -
anthranilate (Antvin), that binds to the vinca site on tubulin, 
inhibits tubulin assembly but does not lead to spiral or other large 
aggregate formation at concentrations up to 1.6 mM. As judged 
by turbidity, 90° light scattering and fluorescence anisotropy, 
little aggregation could be detected. This is in marked contrast to 
vinblastine and suggests that inhibition of assembly and 
aggregate formation can be dissociated from each other by 
suitable substitution in vinblastine. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
It is well known that low concentrations of the vinca alka-
loids, vinblastine and vincristine, reduce microtubule dynam-
ics, inhibit polymerization at intermediate concentrations, and 
lead to the formation of spirals, paracrystals and other aggre-
gates at high concentrations [1-3]. Attempts to ascribe these 
opposing effects to binding at different sites have been rejected 
on the basis of linkage between binding and self-association of 
tubulin, yielding a thermodynamic cycle that requires only a 
single vinblastine binding site [4,5]. Indeed, only one high 
affinity binding site is readily demonstrable by photocrosslink-
ing with a fluorescent vinblastine derivative, vinblastine-4'-an-
thranilate (AntVin) [6]. This derivative inhibits tubulin poly-
merization with an IC50 of 4.8 μΜ, shows an apparent 
binding constant of ~ 4 0 μΜ, is competitively displaced by 
vinblastine or maytansine, and is covalently attached to resi-
dues 172-213 of ß-tubulin upon irradiation at the anthranilate 
absorption. Because of potential linkage between binding and 
self-association, it was important to ascertain whether tubulin 
self-association, as caused by vinblastine, would complicate 
interpretation of AntVin binding [4,5]. To our surprise a large 
molar excess of AntVin failed to promote the formation of 
tubulin aggregates as measured by turbidity. Because this de-
rivative might offer clues to the relation between the polymer-
ization-inhibiting and aggregation-promoting effects of the 
vinca alkaloids, we present here details of the difference in 
the interaction between Antvin and tubulin on the one 
hand, and vinblastine and tubulin on the other. 
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ether) 7V,JV'-tetraacetic acid; DMSO, dimethyl sulfoxide 
Vinblastine-4'-anthranilate (AntVin) was synthesized from vinblas-
tine and isatoic anhydride as previously described Fig. 1 [6]. Pure rat 
brain tubulin was prepared from microtubule protein as described 
[7,8]. Tubulin was labeled with isatoic anhydride at pH 6.9 and a 
molar ratio of 1/1 according to [9]. Assembly and aggregation reac-
tions were carried out at 37°C in 3 mm light path cuvettes with a 
working volume of 100 μΐ in a thermostatted Cary 219 spectropho-
tometer. Studies were carried out with 1.96-2.24 mg/ml of pure rat 
brain tubulin in MES buffer (0.1 M MES pH 6.9, 1 mM EGTA) 
containing 1 mM GTP and 10% dimethyl sulfoxide. Total MgCl2 
concentration was either 1.0 or 6.0 mM. Turbidity was measured at 
400 nm (slit width = 1 nm) to avoid absorption by AntVin. Light 
scattering at 90° was determined in a Perkin Elmer MPF66 spectro-
fluorometer operating in ratio mode (uncorrected, with slits at 5 nm 
each) at room temperature in MES buffer using cuvettes with a 3 mm 
light path. To avoid emission from AntVin excitation was at 450 nm. 
Steady state fluorescence anisotropies were measured at room temper-
ature in MES buffer (no DMSO) with film polarizers inserted into the 
MPF-66 fluorimeter. Excitation was at 330 nm and emission was 
measured at 440 nm. 
3. Results 
A comparison between normal microtubule assembly and 
vinca alkaloid-induced aggregate formation as a function of 
time is depicted in Fig. 2. Because of the absorption of Ant-
Vin at 350 nm, all turbidity observations were made at 400 
nm; as the scattering coefficient (OD40oXml/mg protein) is 
different for micro tubules and spirals etc., direct comparison 
of the OD values cannot be made. Microtubule assembly 
showed the expected lag period and plateau typical of these 
tubulin preparations. When 35 μΜ vinblastine was used, there 
was a rapid increase in the OD400 after a short lag. Electron 
micrographs of these aggregates showed that the bulk of the 
aggregates were composed of single or double spirals many of 
which were clumped together (data not shown). In marked 
contrast to the effects of vinblastine, when a large concentra-
tion (1.6 mM) of AntVin was used, there was virtually no 
increase in the OD400 as a function of time for up to 30 
min. This suggests that no spirals or large aggregates were 
formed by AntVin. 
The concentration of Mg2+ has a profound effect on tubu-
lin polymerization and also on the response to vinca alkaloids. 
The concentration dependence for VLB and AntVin of the 
rate of polymerization and aggregate formation is shown in 
Fig. 3. Both drugs readily prevent microtubule assembly at 
low micromolar concentrations. With 1 mM Mg2+ the IC50 
values were 0.64 and 4.8 μΜ, respectively. After polymeriza-
tion is completely inhibited, there is a region of drug concen-
tration in which there is no change in OD400; its length is a 
function of the Mg2+ concentration. At 1 mM Mg2+ and with 
10% DMSO (solid lines), the OD400 does not increase again 
until 88 μΜ vinblastine is present. The greater concentration 
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Fig. 1. The structures of vinblastine and AntVin. 
of VLB is required because GTP antagonizes the aggregation 
effect (manuscript submitted). High concentrations of Mg2+ 
ion decrease the sensitivity to the inhibiting action of vinblas-
tine on polymerization, changing the IC50 from 0.64 μΜ to 
1.4 μΜ (dashed line). At the same time 6 mM Mg2+ increases 
the sensitivity to vinblastine for tubulin aggregation, shifting 
the curve of rising optical density toward lower concentrations 
(21 μΜ in our experiments at 6 mM MgCl2 [5,9]). Thus, the 
zero AOD40o zone between downward and upward slopes of 
the rates narrows considerably as the Mg2+ concentrations 
increases. When AntVin was used to inhibit tubulin polymer-
ization, the IC50 values were 4.8 μΜ and 11 μΜ resp. for 1 
and 6 mM Mg2+ (Fig. 3). No increase in OD40o occurred even 
with an AntVin concentration of 1.6 mM. This was also true 
at 6 mM Mg2+. The single substitution at C4' of the carbo-
methoxy-velbanamine moiety of vinblastine has thus created 
an analogue of remarkably different properties suggesting that 
dissociation between inhibition of polymerization and spiral 
or aggregate formation can be achieved. 
Because optical density measurements are not very sensitive 
to the presence of smaller oligomers, we measured light scat-
tering at 90° in a fluorimeter. Measurements were carried out 
at 450 nm to avoid emission of AntVin at lower wavelengths. 
Fig. 4 shows that at 25°C, with both 1 mM Mg2+ (left panel) 
and 6 mM Mg2+ (right panel) and 1.35 mg/ml tubulin, but in 
the absence of added GTP, 30 μΜ vinblastine produced abun-
dant (90°) light scattering as expected, whereas 146 or 292 μΜ 
AntVin (left panel, lower two curves) produced a small in-
crease in scattering (2.3 and 4.7% resp. of VLB scattering). 
At 6 mM Mg2+ the two AntVin curves were superimposed 
(right panel, lower curve) and showed 1.2% as much scattering 
as with VLB. Thus, under optimal conditions for spiral for-
mation, AntVin produces very little increase in light scatter-
ing. Similar results were obtained at 37°C (data not shown). 
As an additional test for the presence of oligomers we com-
pared the fluorescence anisotropies of tubulin with those of 
AntVin bound to a 4-5-fold molar excess of tubulin such that 
the bulk of the analogue would be bound at 1 mM Mg2+. 
Free AntVin had an anisotropy (at 330 nm) of 0.087, tubulin-
bound AntVin had a value of 0.174 (at 330 nm), a value 
comparable to tubulin dimer labeled with anthranilate 
(0.182). This indicates that the AntVin was bound and that 
no significant amounts of larger species were present. 
4. Discussion 
Vinca alkaloid-induced inhibition of tubulin polymerization 
and the promotion of aggregate formation at higher concen-
trations have been linked to occupancy of a single, specific, 
binding site on the tubulin dimer coupled to a drug-induced 
self-association. Although this model does not account for 
high affinity binding with stoichiometries of 2 [11,12] or the 
extremely sensitive ( < 0.1 μΜ) vinblastine effects upon micro-
tubule dynamics [3], it can account for the wide spread in 
published affinity constants on the basis of different solvent 
conditions etc. and self association [1,2]. The present data 
suggest, however, that the linkage of vinca site occupancy 
and aggregation can be separated; i.e. aggregate formation 
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Fig. 2. Effect of AntVin and vinblastine on the polymerization of 
tubulin at low and high MgCl2 concentrations. A: Tubulin was 
polymerized at 37°C in MES assembly buffer (0.1 M MES pH 6.9, 
1 mM EGTA, 1 mM MgCl2) containing 10% DMSO. Curve 1, 1.96 
mg/ml tubulin and 35 μΜ VLB; curve 2, microtubule assembly with 
2.24 mg/ml tubulin and 1 mM GTP; curve 3, 2.24 mg/ml tubulin 
and 1.6 mM AntVin. B: Polymerization as above but with 6 mM 
MgCl2. Curve 1, 1.96 mg/ml tubulin and 15 μΜ VLB; curve 2, mi-
crotubule assembly with 1 mM GTP and 2.24 mg/ml tubulin; curve 
3, 2.24 mg/ml tubulin and 1.6 mM AntVin. Turbidity was measured 
at 400 nm in cells with 0.3 mm path length. 
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Fig. 3. Maximal rate of polymerization data (AOD^o/min) of tubu-
lin (2.2 mg/ml) with increasing concentrations of AntVin and VLB 
at 1 or 6 mM MgCl2 in MES buffer pH 6.9 with 10% DMSO, 
1 mM EGTA and 1 mM GTP. The numbers 1 and 6 refer to the 
MgCl2 concentrations in the presence of VLB, whereas encircled 
numbers are MgCl2 concentrations in the presence of AntVin. Be-
cause GTP affects the response to VLB (to be published), the results 
of Fig. 2 cannot be directly compared with those presented here, o , 
VLB+1 mM MgCl2; D, VLB+6 mM MgCl2; Δ, AntVin+1 mM 
MgCl2; « = AntVin+6 mM MgCl2. 
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Fig. 4. 90° light scattering measurements of tubulin in the presence 
of either VLB or AntVin. 1.35 mg/ml tubulin in MES buffer con-
taining (A) 1 mM MgCl2 and (B) 6 mM MgCl2 was measured at 
25°C and 450 nm for both excitation and emission (uncorrected, 
low gain). All curves were corrected by subtraction of the small 
amount of scatter produced by tubulin alone. Curve 1, 30 μΜ 
VLB; curve 2, 292 μΜ AntVin; curve 3, 146 μΜ AntVin. The un-
corrected values with 1 mM MgC^ yielded 16.6, 18.5 and 20.5% as 
much scatter as with VLB for tubulin alone, 146 μΜ and 292 μΜ 
AntVin, respectively. With 6 mM MgCb the respective values were 
3.1, 4.2 and 4.2%. 
is not an obligatory consequence of site occupancy even at 
drug concentrations > 1 mM and with high Mg2+. It also 
suggests that the measured value of the binding constant of 
this derivative [6] is not compromised by significant self-asso-
ciation. Such dissociation can also be found for certain other 
congeners of vinblastine in that the ratio of the half-inhibitory 
concentrations and half-stimulatory concentrations for aggre-
gate formation of some analogues shows considerable varia-
tion under otherwise identical conditions [10,13,14]. Borman 
and coworkers [10,14] have shown dissociation of inhibition 
of polymerization and spiral formation by several C4' vinblas-
tine alkyl derivatives (C20' in their terminology). This sug-
gested a mechanistic difference between low and high concen-
tration activities for these derivatives. Thus, changes in the 
potency for inhibiting assembly are not reflected in the po-
tency for spiral aggregate formation. The results with the 
anthranilate substitution reported here show a marked en-
hancement in the distinction between these two properties of 
VLB. Finally, the 16'-r-butyl-maleyl vinblastine analogue has 
good affinity for tubulin but does not induce spiral formation 
[13]. This behavior is like that of AntVin. Additional evidence 
that microtubule assembly inhibition and aggregation can be 
separated comes from studies with the macrolide, maytansine. 
It has a single, high affinity binding site on tubulin, is a com-
petitive inhibitor of vinblastine binding, is a potent inhibitor 
of tubulin polymerization, but does not promote the forma-
tion of spirals or other aggregates [15-17]. It can, in fact, 
potently inhibit spiral formation by vinblastine, and displace 
VLB from its site. Similar results have been obtained with 
rhizoxin [18], another macrolide that interacts at the vinca 
site. 
The most parsimonious conclusion, therefore, is that the 
two different responses of tubulin to vinca alkaloids could 
result from different sensitivities of the assembly and aggrega-
tion processes to the different congeners. Two different bind-
ing sites are not necessarily required, although two different 
loci within the single binding site would have to be postulated 
to remain consistent with competitive binding on the one 
hand, and different morphological effects on the other. Several 
mechanistic interpretations can be considered. Vinblastine 
analogues produce conformational changes in tubulin (as 
does colchicine) and prevent microtubule assembly, but differ 
from conformational changes that promote aggregation to 
spirals etc. Alternatively, certain substitutions on vinblastine 
sterically inhibit spiral formation or prevent interaction with 
the domains required for spiral formation, but do not prevent 
changes required for inhibition of assembly. Finally, a portion 
of the binding site leading to assembly inhibition is distinct 
from that portion promoting spiral formation; AntVin and 
maytansine occupy only the former portion of the binding 
site. The present data cannot distinguish between these possi-
bilities. Nevertheless, under the appropriate conditions and 
with the appropriate congener mere occupancy of the vinca 
site does not obligate spiral formation, i.e. binding and aggre-
gation are not necessarily linked. 
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